Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events 2020 aad annual meeting
… Data During the COVID-19 Outbreak Share on: April 9, 2020 Updated November 10, 2020 Experts on our Patient-Centered Outcomes Assessment …
… Outcomes in Clinical Trials Share on: September 3, 2020 On August 31, 2020, the FDA released its draft guidance titled “Principles …
Regulatory Guidance and Support We can support you throughout your regulatory negotiations. Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide variety of reviewing divisions on numerous occasions to select and …
… span of four weeks. We were able to submit the work to the annual meeting of the International Society for Pharmacoeconomics …
… Care Knowledge Centre, 2012); Kennedy-Martin et al. (2020) Bulgaria National Center for Public Health and Analysis … Public Health and Analysis, 2018); Kennedy-Martin et al. (2020) Brazil DECIT-CGATS G, TTO, EQ-5D, or SF-6D. … de Salud de Chile, 2013); Kennedy-Martin et al. (2020) China No policy-generating agency Indirect utility …
Systematic and Other Literature Reviews We design literature reviews to meet your needs, dependent on the questions you need answered. Systematic literature reviews are appropriate when you need to answer a clearly-formulated question, when reproducibly …
… Disease information Product information Version 4.1 (2020) At the October 2019 AMCP Nexus meeting, the AMCP Format Executive Committee (FEC) provided … economic models likely not possible AMCP Format 4.1 (2020) Related Services Market Access and Outcomes Strategy …
… evidence ratings in evidence reports for new drugs in 2020 and 2021. Ronquest N , Clinkscales M, Paret K. … ratings were reviewed, across 17 assessments published in 2020 and 2021. As part of our analysis, we identified trends …
RTI-HS researcher to lead study that will seek perspectives of those affected by Alzheimer’s Share on: May 22, 2018 Understanding What Matters Most to Alzheimer's patients and their caregivers to help inform the drug development process. The Alzheimer’s …
Global Value Dossiers and Other Value Communication Materials Your messages need to be flexible, tailored to each of your audiences, and clearly articulated. Let us help develop your global value dossiers (GVDs) and other high-impact communication tools …